The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2019 | CAR-T treatment outcomes: MM real-world data
Yi Lin
• 13 Jun 2019
With two regularly approved CD19 CAR T-cell treatments, Yi Lin, MD, PhD, Mayo Clinic, Rochester, MN, speaks on the importance of real-world data. So far, there are comparable side effects in terms of cytokine release syndrome, neurotoxicity, as well as, clinical response. This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.
